BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15675343)

  • 1. [Discovery of disease biomarkers by ProteinChip system; clinical proteomics as noninvasive diagnostic tool].
    Tomosugi N
    Rinsho Byori; 2004 Dec; 52(12):973-9. PubMed ID: 15675343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel application of ProteinChip technology exploring acute rejection markers of rat small bowel transplantation.
    Yamayoshi Y; Watanabe T; Tanabe M; Hoshino K; Matsumoto K; Morikawa Y; Shimadzu M; Kitajima M; Tanigawara Y
    Transplantation; 2006 Aug; 82(3):320-6. PubMed ID: 16906028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
    Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
    J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic patterns: their potential for disease diagnosis.
    Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):95-106. PubMed ID: 15664456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
    Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
    Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
    Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
    Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
    Ndao M
    Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry).
    Reichelt O; Müller J; von Eggeling F; Driesch D; Wunderlich H; Schubert J; Gröne HJ; Stein G; Ott U; Junker K
    Urology; 2006 Mar; 67(3):472-5. PubMed ID: 16527560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
    Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
    Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-enhanced laser desorption/ionization mass spectrometry for protein and Peptide profiling of body fluids.
    Gagnon A; Shi Q; Ye B
    Methods Mol Biol; 2008; 441():41-56. PubMed ID: 18370310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-source decay causes artifacts in SELDI-TOF MS spectra.
    Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
    J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.